Lack of Drug‐Drug Interaction Between Filgotinib, a Selective JAK1 Inhibitor, and Oral Hormonal Contraceptives Levonorgestrel/Ethinyl Estradiol in Healthy Volunteers-Reference-Cited by-同舟云学术

Lack of Drug‐Drug Interaction Between Filgotinib, a Selective JAK1 Inhibitor, and Oral Hormonal Contraceptives Levonorgestrel/Ethinyl Estradiol in Healthy Volunteers

Published:2020-09-28 Issue:4 Volume:10 Page:376-383
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Begley Rebecca¹,Anderson Kacey¹,Watkins Timothy R.¹,Weng Winnie¹,Ampaw Lorraine¹,Qin Ann¹,Kearney Brian P.¹,Mathias Anita¹

Affiliation:

1. All authors are employed by Gilead Sciences, Inc. Foster City California USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.870

Reference22 articles.

1. Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases

2. JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects

3. Therapeutic Efficacy of Suppressing the JAK/STAT Pathway in Multiple Models of Experimental Autoimmune Encephalomyelitis

4. Therapeutic Targeting of the JAK/STAT Pathway

5. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease☆

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of filgotinib in ulcerative colitis and Crohn’s disease;Immunotherapy;2024-02

2. Bewertung von Wechselwirkungen und Dosierungsempfehlungen von synthetischen DMARDs – Evidenz- und konsensbasierte Empfehlungen auf Basis einer systematischen Literatursuche;Zeitschrift für Rheumatologie;2023-10-13

3. Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens;Contraception;2023-05

4. JAK-inhibitors: clinical pharmacology and application perspectives;Reviews on Clinical Pharmacology and Drug Therapy;2023-03-06

5. Bewertung von Wechselwirkungen und Dosierungsempfehlungen von synthetischen DMARDs – Evidenz- und konsensbasierte Empfehlungen auf Basis einer systematischen Literatursuche;Zeitschrift für Rheumatologie;2023-01-12